Outcome measures used in trials on gait rehabilitation in multiple sclerosis: A systematic literature review.

L Santisteban,A Rodriguez-Larrad,J Irazusta,M Teremetz,P G Lindberg,Peter Schwenkreis

doi:10.1371/journal.pone.0257809

L Santisteban, A Rodriguez-Larrad + Show 4 more

Open Access

https://doi.org/10.1371/journal.pone.0257809

Copy DOI

Abstract

BackgroundMultiple Sclerosis (MS) is associated with impaired gait and a growing number of clinical trials have investigated efficacy of various interventions. Choice of outcome measures is crucial in determining efficiency of interventions. However, it remains unclear whether there is consensus on which outcome measures to use in gait intervention studies in MS.ObjectiveWe aimed to identify the commonly selected outcome measures in randomized controlled trials (RCTs) on gait rehabilitation interventions in people with MS. Additional aims were to identify which of the domains of the International Classification of Functioning, Disability and Health (ICF) are the most studied and to characterize how outcome measures are combined and adapted to MS severity.MethodsPubmed, Cochrane Central, Embase and Scopus databases were searched for RCT studies on gait interventions in people living with MS according to PRISMA guidelines.ResultsIn 46 RCTs, we identified 69 different outcome measures. The most used outcome measures were 6-minute walking test and the Timed Up and Go test, used in 37% of the analyzed studies. They were followed by gait spatiotemporal parameters (35%) most often used to inform on gait speed, cadence, and step length. Fatigue was measured in 39% of studies. Participation was assessed in 50% of studies, albeit with a wide variety of scales. Only 39% of studies included measures covering all ICF levels, and Participation measures were rarely combined with gait spatiotemporal parameters (only two studies).ConclusionsSelection of outcome measures remains heterogenous in RCTs on gait rehabilitation interventions in MS. However, there is a growing consensus on the need for quantitative gait spatiotemporal parameter measures combined with clinical assessments of gait, balance, and mobility in RCTs on gait interventions in MS. Future RCTs should incorporate measures of fatigue and measures from Participation domain of ICF to provide comprehensive evaluation of trial efficacy across all levels of functioning.

Highlights

Multiple Sclerosis (MS) is an inflammatory demyelinating chronic disease of the central nervous system, and it is the most common non-traumatic cause of disability among young adults [1]
Cochrane Central, Embase and Scopus databases were searched for randomized controlled trials (RCTs) studies on gait interventions in people living with MS according to PRISMA guidelines
In 46 RCTs, we identified 69 different outcome measures

Summary

Introduction

Multiple Sclerosis (MS) is an inflammatory demyelinating chronic disease of the central nervous system, and it is the most common non-traumatic cause of disability among young adults [1]. With advances in the field of technology and neurorehabilitation, there have been a growing number of new rehabilitation approaches and RCTs to assess their efficacy [8]. Assessment in this context is central and selecting the most appropriate outcome measures is crucial for determining which rehabilitation treatments are most efficient [9]. Multiple Sclerosis (MS) is associated with impaired gait and a growing number of clinical trials have investigated efficacy of various interventions. Choice of outcome measures is crucial in determining efficiency of interventions

Methods

Results

Conclusion